M&G Investment Management’s GoodRx Holdings GDRX Stock Holding History

M&G Investment Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-258,561	Closed	-$1.29K	–	448
2022 Q3	$1.29K	Buy	+258,561	New	+$1.63M	0.01%	294

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

M&G Investment Management's GDRX Position: Q4 2022 in Review

M&G Investment Management sold out of GoodRx Holdings (GDRX) in Q4 2022, closing a stake of 258,561 shares — an estimated $1.29K sold.

M&G Investment Management first reported a position in GDRX in Q3 2022 and held it in 1 quarter. The position peaked at $1.29K in Q3 2022. 160 funds tracked by Wall St. Rank hold GDRX as of Q4 2022.

M&G Investment Management reported no remaining GoodRx Holdings position as of Q4 2022 after selling out during the quarter.
M&G Investment Management sold 258,561 GoodRx Holdings shares in Q4 2022, an estimated $1.29K.
M&G Investment Management first reported a position in GoodRx Holdings in Q3 2022 and held it in 1 quarter.
M&G Investment Management's GoodRx Holdings position peaked at $1.29K in Q3 2022.
160 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2022.

Based on M&G Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.